Denver’s Kindman Cannabis Calls for Greater Transparency by Colorado Regulators, Following Last Week’s Pesticide Recall Announcement
Denver, Colorado (PRWEB) March 22, 2016 -- In the wake of a dispute over legal marijuana testing procedures and an announced recall, the founder of Denver-based Kindman cannabis is calling for greater transparency and collaboration between industry stakeholders and the state of Colorado regarding its testing protocols for marijuana products.
Last week the state’s Marijuana Enforcement Division (MED) said cannabis samples from Denver-based Kindman came back positive for trace amounts of a banned insecticide.
According to that announcement, samples of Kindman cannabis allegedly contained a detectable amount of imidacloprid, an insecticide commonly used in mainstream agriculture but banned last year by Colorado officials for use on cannabis. The MED also announced a recall of Kindman products going back two years.
Kindman CEO Ryan Fox denies imidiacloprid is used in his company’s cannabis grow operations. Soon after the recall was announced Kindman said it was filing a Colorado Open Records Act (CORA) request, to determine exactly how the state’s Department of Agriculture (CDA) testing procedures are conducted.
“The state won’t allow for retests of cannabis samples it says are contaminated, so there’s no way for us to verify their results,” he says. “And once the recall announcement has been made there’s virtually nothing a company can do but start over."
There have been dozens of cannabis recalls in Colorado over the past several months, due to allegations of pesticide usage.
But Noel Palmer describes Colorado’s cannabis testing procedures as “challenging on many levels,” due to the enormity of an unprecedented effort by Colorado at marijuana testing.
Palmer has a Masters and PhD in analytical chemistry and specializes in analytics, laboratory protocol and proper laboratory etiquette. Recognized as 2014 Researcher of the Year by Americans for Safe Access, he was involved in drafting the Industry Standards for Laboratory Testing of cannabis.
A big part of the issue with Colorado’s testing protocols, he says, is the current ambiguity surrounding these quality control regulations for the overall legal cannabis industry.
“Public health is paramount,” he says. “Customers need confidence in the products that they buy. Regulators must collaborate with industry stakeholders to ensure that testing protocols are clearly established and certified testing facilities are available.”
Palmer hopes that Kindman will share the results of its CORA request with the cannabis industry’s scientific community, in order to help Colorado’s legal cannabis businesses determine exactly what is required of them when it comes to current and future cannabis production.
ABOUT KINDMAN
Established in 2009, Kindman provides customers with an unmatched cannabis product – grown in Colorado state-regulated facilities at indoor locations, using a customized process that combines food-grade nutrients and a unique soil mix that brings out the plant's best features. Close attention is paid to product cleanliness, quality, curing and processing.
Since the January 1, 2014 start of legalized sales of recreational cannabis to adults in Colorado, Kindman has provided high-quality marijuana flowers to tens of thousands of customers from over 100 countries.
For more information, visit: http://www.kindmancolorado.com/
Bruce Kennedy, WeedLife Network, +1 404-259-1231, [email protected]
Share this article